Literature DB >> 20650224

Evaluation of a modified HET-CAM assay as a screening test for eye irritancy.

L Gilleron1, S Coecke, M Sysmans, E Hansen, S Van Oproy, D Marzin, H Van Cauteren, P Vanparys.   

Abstract

The hen's egg test-chorioallantoic membrane (HET-CAM) assay, an alternative to the Draize eye irritation test, was developed by Luepke and has been improved on by means of a microscopic examination and the use of a test substance applicator (TSA). The TSA is a double teflon ring in which a perlon mesh is locked, and has several advantages over conventional protocols, reducing subjectivity of the method and avoiding the need for rinsing after treatment. It was confirmed by statistical analysis that the HET-CAM-TSA method can reproduce potentialin vivo irritant effects on the conjunctiva. The classification based on thein vitro results was compared with fourin vivo classifications [MAS (maximal average score) with thresholds of 15.0 and 25.0; the Kay and Calandra method; and EC criteria]. Cooper's parameters (specificity, sensitivity and concordance with the Draize test) were calculated according to these fourin vivo classifications. When the most rigorous classification (MAS threshold of 15.0) was taken into account, a sensitivity of 80%, a specificity of 81.3% and a concordance with the Draize test of 80.4% were obtained for this set of 46 compounds.

Entities:  

Year:  1996        PMID: 20650224     DOI: 10.1016/0887-2333(96)00021-5

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  8 in total

1.  G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis.

Authors:  L F F Bittencourt; G L Negreiros-Lima; L P Sousa; A G Silva; I B S Souza; R I M A Ribeiro; M F Dutra; R F Silva; A C F Dias; F M Soriani; W K Martins; L S Barcelos
Journal:  J Neurooncol       Date:  2019-08-07       Impact factor: 4.130

2.  Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.

Authors:  Purva Khare; Manasi M Chogale; Pratik Kakade; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2022-05-10       Impact factor: 5.671

3.  Safety and efficacy of 4-terpineol against microorganisms associated with blepharitis and common ocular diseases.

Authors:  Chen-Wei Su; Sean Tighe; Hosam Sheha; Anny M S Cheng; Scheffer C G Tseng
Journal:  BMJ Open Ophthalmol       Date:  2018-06-04

4.  A New Topical Eye Drop Containing LyeTxI-b, A Synthetic Peptide Designed from A Lycosa erithrognata Venom Toxin, Was Effective to Treat Resistant Bacterial Keratitis.

Authors:  Carolina Nunes da Silva; Flavia Rodrigues da Silva; Lays Fernanda Nunes Dourado; Pablo Victor Mendes Dos Reis; Rummenigge Oliveira Silva; Bruna Lopes da Costa; Paula Santos Nunes; Flávio Almeida Amaral; Vera Lúcia Dos Santos; Maria Elena de Lima; Armando da Silva Cunha Júnior
Journal:  Toxins (Basel)       Date:  2019-04-04       Impact factor: 4.546

5.  A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis.

Authors:  Niyaz Ahmad; Farhan Jalees Ahmad; Sumit Bedi; Sonali Sharma; Sadiq Umar; Mohammad Azam Ansari
Journal:  Saudi Pharm J       Date:  2019-04-29       Impact factor: 4.330

6.  Azithromycin novel drug delivery system for ocular application.

Authors:  Ritu Mehra Gilhotra; Kalpana Nagpal; Dina Nath Mishra
Journal:  Int J Pharm Investig       Date:  2011-01

7.  Retrospective analysis of the Draize test for serious eye damage/eye irritation: importance of understanding the in vivo endpoints under UN GHS/EU CLP for the development and evaluation of in vitro test methods.

Authors:  Els Adriaens; João Barroso; Chantra Eskes; Sebastian Hoffmann; Pauline McNamee; Nathalie Alépée; Sandrine Bessou-Touya; Ann De Smedt; Bart De Wever; Uwe Pfannenbecker; Magalie Tailhardat; Valérie Zuang
Journal:  Arch Toxicol       Date:  2013-12-28       Impact factor: 5.153

8.  PnPP-19 Peptide as a Novel Drug Candidate for Topical Glaucoma Therapy Through Nitric Oxide Release.

Authors:  Carolina Nunes da Silva; Lays Fernanda Nunes Dourado; Maria Elena de Lima; Armando da Silva Cunha-Jr
Journal:  Transl Vis Sci Technol       Date:  2020-07-22       Impact factor: 3.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.